JP2012521207A5 - - Google Patents

Download PDF

Info

Publication number
JP2012521207A5
JP2012521207A5 JP2012501286A JP2012501286A JP2012521207A5 JP 2012521207 A5 JP2012521207 A5 JP 2012521207A5 JP 2012501286 A JP2012501286 A JP 2012501286A JP 2012501286 A JP2012501286 A JP 2012501286A JP 2012521207 A5 JP2012521207 A5 JP 2012521207A5
Authority
JP
Japan
Prior art keywords
bordetella
polypeptide
seq
sequence
cyaa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012501286A
Other languages
English (en)
Japanese (ja)
Other versions
JP5770711B2 (ja
JP2012521207A (ja
Filing date
Publication date
Priority claimed from US12/409,324 external-priority patent/US8017132B2/en
Priority claimed from EP09155929.4A external-priority patent/EP2233569B1/en
Application filed filed Critical
Priority claimed from PCT/EP2010/053795 external-priority patent/WO2010136231A1/en
Publication of JP2012521207A publication Critical patent/JP2012521207A/ja
Publication of JP2012521207A5 publication Critical patent/JP2012521207A5/ja
Application granted granted Critical
Publication of JP5770711B2 publication Critical patent/JP5770711B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012501286A 2009-03-23 2010-03-23 細胞中への免疫原性分子のデリバリーに適したCyaAポリペプチド突然変異体及びポリペプチド誘導体 Expired - Fee Related JP5770711B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12/409,324 US8017132B2 (en) 2009-03-23 2009-03-23 Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell
EP09155929.4A EP2233569B1 (en) 2009-03-23 2009-03-23 Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell
US12/409,324 2009-03-23
EP09155929.4 2009-03-23
PCT/EP2010/053795 WO2010136231A1 (en) 2009-03-23 2010-03-23 MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELL

Publications (3)

Publication Number Publication Date
JP2012521207A JP2012521207A (ja) 2012-09-13
JP2012521207A5 true JP2012521207A5 (cg-RX-API-DMAC10.html) 2013-05-09
JP5770711B2 JP5770711B2 (ja) 2015-08-26

Family

ID=42224889

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012501286A Expired - Fee Related JP5770711B2 (ja) 2009-03-23 2010-03-23 細胞中への免疫原性分子のデリバリーに適したCyaAポリペプチド突然変異体及びポリペプチド誘導体

Country Status (7)

Country Link
EP (1) EP2411513B1 (cg-RX-API-DMAC10.html)
JP (1) JP5770711B2 (cg-RX-API-DMAC10.html)
CN (2) CN102439146A (cg-RX-API-DMAC10.html)
CA (1) CA2755694A1 (cg-RX-API-DMAC10.html)
ES (1) ES2612945T3 (cg-RX-API-DMAC10.html)
RU (1) RU2585216C2 (cg-RX-API-DMAC10.html)
WO (1) WO2010136231A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2690172A1 (en) * 2012-07-23 2014-01-29 Genticel CYAA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses
EP2975120A1 (en) 2014-07-17 2016-01-20 Institut Pasteur Monomeric and functional adenylate cyclase CyaA toxin
WO2018091613A1 (en) * 2016-11-17 2018-05-24 Ecole Nationale Vétérinaire de Toulouse Immunogenic and vaccine compositions for use against bordetella bronchiseptica infection
EP3323426A1 (en) * 2016-11-17 2018-05-23 Ecole Nationale Vétérinaire de Toulouse Immunogenic and vaccine compositions for use against bordetella bronchiseptica infection
EP3381931A1 (en) 2017-03-29 2018-10-03 Mikrobiologicky ustav AV CR, v.v.i. Adenylate cyclase toxoid with reduced cytolytic activity
DE102018215551A1 (de) 2018-09-12 2020-03-12 Virolutions Biotech Gmbh Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
FR2638169B1 (fr) * 1988-10-25 1991-01-11 Pasteur Institut Derives d'adenyl cyclase et leurs utilisations biologiques
EP1715047A3 (en) 1992-04-21 2008-08-27 Institut Pasteur Recombinant mutants for inducing specific immune responses
FR2805544B1 (fr) * 2000-02-28 2004-07-16 Pasteur Institut Adenylcyclase recombinante et procede de tri de molecules a activite proteolytique utilisant cette adenylcyclase
PT1188446E (pt) * 2000-09-15 2009-11-10 Pasteur Institut Vectores proteinácios para a distribuição da molécula a células que expressam cd11b
EP1489092A1 (en) * 2003-06-18 2004-12-22 Institut Pasteur Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof
JP2008500271A (ja) * 2003-10-14 2008-01-10 ザ・プロウボウスト・フェロウズ・アンド・スカラーズ・オブ・ザ・カレッジ・オブ・ザ・ホリー・アンド・アンデバイデッド・トリニティ・オブ・クイーン・エリザベス・ニア・ダブリン 免疫介在性疾患の治療および/または予防におけるアデニル酸シクラーゼ
PL1576967T3 (pl) * 2004-03-18 2008-03-31 Pasteur Institut Rekombinowane białko niosące epitopy ludzkiego wirusa brodawczaka wstawione w białko cyklazy adenylanowej lub jego fragment oraz jego zastosowania terapeutyczne

Similar Documents

Publication Publication Date Title
ES2258796T3 (es) Proteinas de fusion que contienen proteinas de estres para inducir respuestas inmunitarias.
CN116096735A (zh) 乙型冠状病毒的预防和治疗
US6821521B1 (en) Multicomponent meningococcal vaccine
US8445650B2 (en) Mutant botulinum neurotoxin serotype A polypeptide and uses thereof
JP4940479B2 (ja) マイコバクテリウム・ツベルクローシス融合蛋白質及びその応用
JP2024095660A (ja) 虫刺され過敏症の治療
HU229968B1 (hu) Sztreptokokkusz oltóanyag
WO2020249756A1 (en) Fusion proteins for tuberculosis vaccines
JP2012500001A5 (cg-RX-API-DMAC10.html)
JP2011528222A5 (cg-RX-API-DMAC10.html)
KR20150124999A (ko) 암 표적화 치료용 알부민-결합 아르기닌 데이미나제를 포함하는 약제학적 조성물
JP2015536134A5 (cg-RX-API-DMAC10.html)
US10835600B2 (en) Compositions against cat allergy
US11352411B2 (en) Fusion peptides of CD4 helper T cell epitopes and vaccines thereof
KR20160088323A (ko) S. 뉴모니에(S. pneumoniae)에 대항하는 보호성 프롤린-풍부한 펩티드
JP2013505017A5 (cg-RX-API-DMAC10.html)
HRP20140886T1 (hr) MUTANTI CyaA POLIPEPTIDI I POLIPEPTIDNI DERIVATI PRIKLADNI ZA DOPREMANJE IMUNOGENIÄŚNIH MOLEKULA U STANICU
JP2004508065A5 (cg-RX-API-DMAC10.html)
JP2012510289A (ja) グルタミルtRNA合成酵素(GtS)フラグメント
JP2015515276A (ja) ヘパリン結合性赤血球凝集素(hbha)融合タンパク質とその用途をコードする組換え型マイコバクテリウム
RU2011138706A (ru) МУТАНТНЫЕ ПОЛИПЕПТИДЫ СуаА И ПРОИЗВОДНЫЕ ПОЛИПЕПТИДОВ, ПОДХОДЯЩИЕ ДЛЯ ДОСТАВКИ ИММУНОГЕННЫХ МОЛЕКУЛ В КЛЕТКУ
ES2367128T3 (es) Procedimiento para preparar una variante del antígeno protector de superficie de erysipelothrix rhusiopathiae en e. coli.
ES2712647T3 (es) Proteínas quiméricas basadas en HPV/CyaA que comprenden un polipéptido heterólogo y sus usos en la inducción de respuestas inmunes contra infección por HPV y trastornos inducidos por HPV
US20190117756A1 (en) Immunogenic Compositions and Vaccines Derived From Bacterial Surface Receptor Proteins
Moyle et al. Combined synthetic and recombinant techniques for the development of lipoprotein-based, self-adjuvanting vaccines targeting human papillomavirus type-16 associated tumors